A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors

NCT07231211 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: SHR-4610 Injection

Sponsor

Shanghai Shengdi Pharmaceutical Co., Ltd